Resmed (RMD) Stock Price
$247 1.7%
to add to portfolio
AI Score
-
Alternative
7 -
Fundamental
9 -
Technical
5
Our AI score evaluates a company's performance on a scale from 0 to 10 by analyzing alternative data points — web traffic, app downloads, job postings, etc - along with financial health and technical signals. Scores below 4 project bearish performance, while scores above 6 project bullish performance.
Sign up to get access to more historical data and insights on Resmed, AI stock picks, stock alerts and much more.
RMD AI Stock Analysis
AI stock analysis for RMD is missing at the moment.
Our AI stock analysis reviews financial data, technical analysis, and alternative data insights to project stock performance. For example, analyzing a company like Resmed (RMD) provides a clear summary of future projections. Gain the edge you need to make confident, data-driven investment decisions.
Sign up and become a member to get access to AI stock analysis.
Sign up
Resmed (RMD) Price Prediction
Based on a combination of financial analysis, technical indicators, and insights from alternative data, we predict that the stock price of Resmed (RMD), currently trading at $247, will... Sign up to access price prediction.
Disclaimer:
This prediction is provided for informational purposes only and does not constitute financial advice. Market conditions are subject to change, and past performance is not indicative of future results. Please conduct your own research or consult a professional before making investment decisions.
About RMD
-
ResMed Inc.
-
Symbol
RMD
-
Market
NYSE
-
Industry
Medical - Instruments & Supplies
-
Market Cap
36.2B
Similar Stocks
 |
Becton Dickinson and Co BDX |
$175.4 2.3% |
4 |
 |
Envista Holdings NVST |
$18.02 7.8% |
4 |
 |
Baxter International BAX |
$30.87 2.5% |
4 |
 |
West Pharmaceutical Services WST |
$210.6 2.4% |
6 |
 |
Teleflex TFX |
$123 1.8% |
5 |
News
RMD Alternative Data
Web Traffic
Resmed receives an estimated 2.9M monthly visitors to resmed.com.
-
Web Traffic
2895402
-
Change from Previous Month
5%
-
3 Month Change
0.1%
-
YoY Change
0.1%
Twitter Followers
Resmed has 10,532 Twitter Followers on its main Twitter (also known as X) account, which is up by 0.1% over the last month.
-
Twitter Followers
10532
-
Daily Change
0%
-
1 Month Change
0.1%
-
3 Month Change
0.1%
-
YoY Change
0.1%
Facebook Engagement
Resmed has engaged 2,612 users via their Facebook Page over the last 7 days.
-
Facebook Engagement
2612
-
Daily Change
2.1%
-
1 Month Change
642%
-
3 Month Change
108.5%
-
YoY Change
108.5%
Instagram Followers
Resmed has 7,682 Instagram Followers on its main Instagram account, up by 6% over the last month.
-
Instagram Followers
7682
-
Daily Change
0.4%
-
1 Month Change
6%
-
3 Month Change
19.5%
-
YoY Change
19.5%
Youtube Subscribers
Resmed has 51,200 subscribers on its main Youtube channel, up by 1.8% over the last month.
-
Youtube Subscribers
51200
-
Daily Change
0.2%
-
1 Month Change
1.8%
-
3 Month Change
5.1%
-
YoY Change
5.1%
Reddit Mentions
Resmed has been mentioned an estimated 0 times in investment subreddits on Reddit over the last 24 hours.
-
Reddit Mentions
0
-
Daily Change
0%
-
1 Month Change
0%
-
3 Month Change
100%
LinkedIn Followers
216,000 are following Resmed on LinkedIn, up by 1.3% over the last month.
-
LinkedIn Followers
216000
-
Daily Change
0%
-
1 Month Change
1.3%
-
3 Month Change
5.2%
Job Postings
Resmed currenly has an estimated 357 open job postings, up by 2.3% over the last month.
-
Job Postings
357
-
Daily Change
0.8%
-
1 Month Change
2.3%
-
3 Month Change
6.1%
-
YoY Change
6.1%
LinkedIn Employees
According to LinkedIn, Resmed has 8,213 employees, up by 0.9% over the last month.
-
LinkedIn Employees
8213
-
Daily Change
0%
-
1 Month Change
0.9%
-
3 Month Change
2.3%
-
YoY Change
2.3%
Business Outlook
According to employee reviews, the business outlook among employees at Resmed is 78 out of 100 (bullish).
-
Business Outlook
78
-
Change from Previous Month
0%
-
3 Month Change
2.6%
-
YoY Change
2.6%
News Mentions
Resmed was mentioned 4 times in the news yesterday.
-
News Mentions
4
-
Daily Change
100%
-
1 Month Change
0%
-
3 Month Change
100%
App Downloads
-
App Downloads
0
-
1 Month Change
0%
-
3 Month Change
0%
-
YoY Change
0%
RMD Financials
RMD Key Metrics
-
Total Revenue
$1.3B
-
Net Income
$365M
-
Earnings per Share
$2.49
-
Free cash flow
$554.9M
-
EBITDA
$478.2M
-
EBITDA Ratio
0.370183
-
Total Assets
$7.6B
RMD 2-year Revenue & Income
RMD 2-year Free Cash Flow
RMD Technicals
RMD SMA
RMD RSI
FAQ
What's the current price of Resmed (RMD) Stock?
The price of an Resmed (RMD) share is $247.
What's the market cap of Resmed?
The current market cap of Resmed is 36.2B.
Should I buy or sell RMD?
Multiple alternative data signals suggest that Resmed stock could offer a buying opportunity at its current level, with a reasonable expectation for positive performance in the mid term.
Is Resmed a good investment?
Based on an in-depth analysis that encompasses fundamentals, technical analysis, and alternative data insights, it appears to be a favorable time to consider investing in Resmed stock. The bullish indicators suggest that Resmed's growth prospects and market position may lead to a positive performance in the foreseeable future.
Is now a good time to buy Resmed (RMD) Stock?
Based on an analysis that includes fundamentals, technical analysis, and alternative data insights, it could be a favorable time to consider buying Resmed stock, given the bullish outlook.
What are some stocks similar to Resmed (RMD) that investors often compare it to?
Resmed (RMD) is often compared to similar stocks such as Becton Dickinson and Co, Envista Holdings, Baxter International, West Pharmaceutical Services and Teleflex.
What is the forecast for Resmed's stock price in 2026?
Using a mix of financial analysis, technical indicators, and alternative data, we forecast Resmed's stock price to be around $267.5 in 2026. Starting from the current price of $247, this represents a 8.3% change in price, indicating a bullish outlook for the stock.
How to buy Resmed (RMD) Stock?
Resmed stock is available for purchase through numerous brokerage firms, including online platforms. Investors can also buy Resmed shares via trading apps on their smartphones or by utilizing services like robo-advisors for automated investing.